Search - tctmd.com

Displaying 541 - 560 of 861

Sort: Relevancy | Date

News Industry News

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 29, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

News Industry News

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Conference News TCT 2013

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

October 29, 2013

Presentation TCT 2013

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

Presenter: Yu Taniguchi

October 29, 2013

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

Presentation TCT 2013

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Presenter: Alex Rothman

October 28, 2013

Presentation TCT 2013

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Presenter: Shao Liang Chen

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

Changing Vessel Compliance to Treat Hypertension (Rox Medical)

Presenter: David Deaton

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

Presentation TCT 2013

Autonomic Regulation of the Cardiovascular System in Hypertension and Heart Failure: State-of-the-Art

Presenter: Paul Sobotka

October 28, 2013

Presentation TCT 2013

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

Presenter: David Kandzari

October 27, 2013

Presentation TCT 2013

Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology?

Presenter: Robert Whitbourn

October 27, 2013

Presentation TCT 2013

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Presenter: Jan Pietzsch

October 27, 2013

Advertisement

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Preliminary Data Show Potential of Renal Denervation in Several Settings

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Changing Vessel Compliance to Treat Hypertension (Rox Medical)

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Autonomic Regulation of the Cardiovascular System in Hypertension and Heart Failure: State-of-the-Art

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology?

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content